• Subscribe
  • Webinars
  • White Papers
  • Buyer's Guide
  • PhotonicsNXT
  • Get Published!
    • Recent Quotes
    My Watchlist
    Indicators
    BioOptics Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Markets:
    Overview
    News
    Currencies
    International
    Treasuries

    MacroGenics, Inc. - Common Stock (NQ:MGNX)

    3.995 +0.095 (+2.44%)
    Streaming Delayed Price Updated: 10:20 AM EDT, Aug 6, 2026 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 51,859
    Open 3.950
    Bid (Size) 3.980 (700)
    Ask (Size) 3.990 (400)
    Prev. Close 3.900
    Today's Range 3.950 - 4.055
    52wk Range 1.290 - 5.080
    Shares Outstanding 61,107,288
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    News headline image
    MacroGenics Provides Clinical Update on Ongoing Phase 1 Study for MGC026
    From MacroGenics, Inc.
    Via GlobeNewswire
    News headline image
    Bora Pharmaceuticals Completes Acquisition of MacroGenics’ Rockville Manufacturing Operations
    TAIPEI, TAIWAN - Media OutReach Newswire - 2 July 2026 - Bora Pharmaceuticals Co., Ltd. ("Bora" or "Bora Group"; TWSE: 6472; OTCQX: BORAY) today announced... 
    Via MediaOutReach
    Topics Economy

    Performance

    YTD
    +148.1%
    +148.1%
    1 Month
    -12.6%
    -12.6%
    3 Month
    +32.7%
    +32.7%
    6 Month
    +130.9%
    +130.9%
    1 Year
    +136.4%
    +136.4%

    More News

    Read More
    News headline image
    MacroGenics Completes Sale of GMP Manufacturing Operations to Bora Pharmaceuticals
    From MacroGenics, Inc.
    Via GlobeNewswire
    News headline image
    MacroGenics to Receive Milestone Payment from Sanofi for Recent TZIELD® Approval
    From MacroGenics, Inc.
    Via GlobeNewswire
    News headline image
    MacroGenics Eyes $200M Cash Boost, 2028 Runway Ahead of Cancer Pipeline Updates ↗
    Via MarketBeat
    News headline image
    MacroGenics to Participate in the Stifel 2026 Virtual Targeted Oncology Forum
    From MacroGenics, Inc.
    Via GlobeNewswire
    Let's uncover which stocks are experiencing notable gaps during today's session. ↗
    Via Chartmill
    News headline image
    MacroGenics to Sell GMP Manufacturing Operations to Bora Pharmaceuticals
    From MacroGenics, Inc.
    Via GlobeNewswire
    News headline image
    MacroGenics and Sagard Healthcare Partners Enter into Expanded ZYNYZ® Royalty Purchase Agreement
    From MacroGenics, Inc.
    Via GlobeNewswire
    News headline image
    MGNX Closes Up 45% On Wall Street Optimism For Experimental Cancer Therapies ↗
    Via Stocktwits
    Which stocks are moving on Tuesday? ↗
    Via Chartmill
    Let's have a look at the top gainers and losers in the middle of the day of today's session. ↗
    Via Chartmill
    News headline image
    MacroGenics to Participate in Upcoming Investor Conferences
    From MacroGenics, Inc.
    Via GlobeNewswire
    News headline image
    MacroGenics Announces Pausing of Enrollment of New Study Participants in LINNET Trial
    From MacroGenics, Inc.
    Via GlobeNewswire
    News headline image
    MacroGenics to Participate in the 8th Annual Evercore Healthcare Conference
    From MacroGenics, Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Thursday's Pre-Market Session ↗
    Via Benzinga
    News headline image
    MacroGenics to Participate in the Stifel 2025 Healthcare Conference
    From MacroGenics, Inc.
    Via GlobeNewswire
    News headline image
    What's going on in today's after hours session ↗
    Via Chartmill
    News headline image
    MacroGenics to Present at H.C. Wainwright 27th Annual Global Investment Conference
    From MacroGenics, Inc.
    Via GlobeNewswire
    News headline image
    12 Health Care Stocks Moving In Thursday's After-Market Session ↗
    Via Benzinga
    News headline image
    Thursday's after hours session: top gainers and losers ↗
    Via Chartmill
    News headline image
    MacroGenics Revenue Doubles in Q2 ↗
    Via The Motley Fool
    News headline image
    MacroGenics Appoints Eric Risser as President and Chief Executive Officer
    From MacroGenics, Inc.
    Via GlobeNewswire
    News headline image
    Which stocks have an unusual volume on Wednesday? ↗
    Via Chartmill
    News headline image
    Synergy CHC (NASDAQ: SNYR) Taps Coca-Cola Exec to Accelerate Global Expansion of “FOCUSfactor®” Energy Drink – More Stocks Moving Inside
    Via AB Newswire

    Frequently Asked Questions

    Is MacroGenics, Inc. - Common Stock publicly traded?
    Yes, MacroGenics, Inc. - Common Stock is publicly traded.
    What exchange does MacroGenics, Inc. - Common Stock trade on?
    MacroGenics, Inc. - Common Stock trades on the Nasdaq Stock Market
    What is the ticker symbol for MacroGenics, Inc. - Common Stock?
    The ticker symbol for MacroGenics, Inc. - Common Stock is MGNX on the Nasdaq Stock Market
    What is the current price of MacroGenics, Inc. - Common Stock?
    The current price of MacroGenics, Inc. - Common Stock is 3.995
    When was MacroGenics, Inc. - Common Stock last traded?
    The last trade of MacroGenics, Inc. - Common Stock was at 08/06/26 10:20 AM ET
    What is the market capitalization of MacroGenics, Inc. - Common Stock?
    The market capitalization of MacroGenics, Inc. - Common Stock is 244.12M
    How many shares of MacroGenics, Inc. - Common Stock are outstanding?
    MacroGenics, Inc. - Common Stock has 244M shares outstanding.
    Stock Quote API & Stock News API supplied by www.cloudquote.io
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the Privacy Policy and Terms Of Service.
    © 2025 FinancialContent. All rights reserved.